Breast Imaging Market Size, Share and Global Trend By Imaging Modality (Breast MRI Mammography, Breast Tomosynthesis, Galactography, Scinti-mammography), By End User (Hospitals, Ambulatory Surgery Centres, Diagnostic Centres, Cancer Care Centres), Regional Forecast, 2024-2032

According to American Cancer Society, from 1989 to 2015, the U.S. witnessed 39% reduction in mortality rate of patients suffering from breast cancer and in 2017, there were an estimated 3.1 million breast cancer survivors in the U.S. These statistics are a result of early diagnosis of breast abnormalities.

The Breast Imaging technique is used in the diagnosis of breast-related abnormalities such as fibrocystic breast changes, fibroadenomas, blocked milk ducts, intraductal papillomas, cysts, and others. These breast imaging technologies are used by physicians and oncology surgeons in order to perform diagnosis of breast structure, cells composition, lumps, and other internal parts of the breast. Breast imaging has played a major role in detecting cancer cells and lumps even before they are felt to bare hands, which has led to a reduction in the mortality rate of breast-related disorders worldwide.

Increasing awareness about breast health is one of the prominent drivers for the growth of the global breast imaging market. In October 2018, DenseBreast-info.org broadcasted three informational videos worldwide to educate women about breast density and its implications on breast health. This combined with the growing demand of improved breast diagnosis, increasing prevalence of breast cancer, improved care processes, and prolonged life expectancy of cancer survivors due to proper treatment and accurate diagnosis are factors driving the growth of the global breast imaging market.

Stringent government regulations and increased risk of radiation exposure are expected to hamper the growth of the global breast imaging market during the forecast period. Combined with this, higher acquisition and maintenance cost of breast imaging equipment is also projected to slow the growth of the breast imaging market, especially in emerging nations. 

Key Players Covered 

Some of the major companies that are present in the global breast imaging market are GENERAL ELECTRIC COMPANY, Siemens Ltd., Koninklijke Philips N.V., Hologic Inc., FUJIFILM Holdings Corporation, SonoCiné, Dilon Technologies, Inc., CMR Naviscan, Thorlabs, Inc., Barco, DUNE, and others. 

SEGMENTATION 

Among the imaging modality segments, breast tomosynthesis is anticipated to register comparatively higher share in the global breast imaging market owing to superior image acquisition because of the integration of intelligent algorithms. 

Key Insights 

• Top 3 players operating in the market place
• Key mergers and acquisitions
• Key start-ups with their funding overview
• Applied SWOT analysis 

Regional Analysis 

North America is expected to dominate the global breast imaging market owing to increasing awareness about the early diagnosis of breast cancer and enhanced diagnostic technologies. Asia Pacific and Middle East & Africa regions hold huge potential for global breast imaging market owing to the prevalence of breast disorders in African countries, the rise in awareness about breast disorders by Non-Governmental Organizations and women & child care departments of national governments, and a large undiagnosed patient population in the regions. 

Key Industry Developments

• In September 2018, Texas-based Soil Mammography launched SmartCurve breast imaging technology in more than 50 centers across the U.S. The newly developed device offers higher patient comfort as it provides curved compression surface which is similar to the shape of the breast.
• In October 2018, the Society of Brest Imaging (SBI) announced its collaboration with the Oxford University Press to launch the journal of breast imaging with an aim to spread awareness amongst patients about breast diseases, breast imaging and future trends.
• In October 2018, Telerad Tech launched an artificial intelligence based product, MammoAssist to detect early-based breast cancer.
• In November 2018, Kubtec announced the launch of Mozart Supra Specimen Tomosynthesis System, which is configured to offer 3D imaging for breast cancer surgery.